Neville Rodie & Shaw Inc. maintained its position in shares of Agilent Technologies, Inc. (NYSE:A) during the second quarter, Holdings Channel reports. The fund owned 8,128 shares of the medical research company’s stock at the end of the second quarter. Neville Rodie & Shaw Inc.’s holdings in Agilent Technologies were worth $482,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Skandinaviska Enskilda Banken AB publ boosted its position in shares of Agilent Technologies by 5.7% in the first quarter. Skandinaviska Enskilda Banken AB publ now owns 64,834 shares of the medical research company’s stock valued at $3,428,000 after buying an additional 3,489 shares during the period. British Columbia Investment Management Corp boosted its position in shares of Agilent Technologies by 96.7% in the first quarter. British Columbia Investment Management Corp now owns 357,983 shares of the medical research company’s stock valued at $18,927,000 after buying an additional 175,992 shares during the period. Garde Capital Inc. boosted its position in shares of Agilent Technologies by 4.2% in the fourth quarter. Garde Capital Inc. now owns 13,341 shares of the medical research company’s stock valued at $608,000 after buying an additional 539 shares during the period. Wesbanco Bank Inc. bought a new position in shares of Agilent Technologies during the first quarter valued at approximately $215,000. Finally, Creative Planning boosted its position in shares of Agilent Technologies by 6.3% in the first quarter. Creative Planning now owns 11,961 shares of the medical research company’s stock valued at $632,000 after buying an additional 710 shares during the period.
Shares of Agilent Technologies, Inc. (A) opened at 59.63 on Monday. Agilent Technologies, Inc. has a 52-week low of $42.92 and a 52-week high of $61.15. The firm has a market capitalization of $19.16 billion, a PE ratio of 33.52 and a beta of 1.30. The stock has a 50 day moving average price of $58.94 and a 200-day moving average price of $52.92.
Agilent Technologies (NYSE:A) last announced its earnings results on Monday, May 22nd. The medical research company reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.10. Agilent Technologies had a return on equity of 16.49% and a net margin of 13.41%. The firm had revenue of $1.10 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the previous year, the business earned $0.44 EPS. The company’s revenue was up 8.1% compared to the same quarter last year. Equities analysts forecast that Agilent Technologies, Inc. will post $2.23 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 26th. Investors of record on Monday, July 3rd will be paid a $0.132 dividend. The ex-dividend date of this dividend is Thursday, June 29th. This represents a $0.53 annualized dividend and a yield of 0.89%. Agilent Technologies’s payout ratio is 29.78%.
COPYRIGHT VIOLATION NOTICE: “Neville Rodie & Shaw Inc. Has $482,000 Stake in Agilent Technologies, Inc. (A)” was first posted by WKRB News and is owned by of WKRB News. If you are viewing this article on another website, it was copied illegally and reposted in violation of United States and international copyright laws. The correct version of this article can be accessed at https://www.wkrb13.com/markets/2285314/neville-rodie-shaw-inc-has-482000-stake-in-agilent-technologies-inc-a.html.
Several research analysts recently commented on A shares. Deutsche Bank AG reissued a “buy” rating and set a $58.00 price target (up from $56.00) on shares of Agilent Technologies in a research report on Sunday, April 2nd. Jefferies Group LLC reissued a “buy” rating and set a $59.00 price target on shares of Agilent Technologies in a research report on Friday, March 17th. Morgan Stanley increased their price target on Agilent Technologies from $65.00 to $70.00 and gave the company an “overweight” rating in a research report on Wednesday, May 24th. BTIG Research increased their price target on Agilent Technologies from $57.00 to $65.00 and gave the company a “buy” rating in a research report on Wednesday, May 24th. Finally, BidaskClub cut Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. One investment analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $59.62.
In related news, CEO Michael R. Mcmullen sold 32,511 shares of the company’s stock in a transaction that occurred on Monday, May 1st. The stock was sold at an average price of $55.48, for a total value of $1,803,710.28. Following the transaction, the chief executive officer now owns 260,346 shares in the company, valued at $14,443,996.08. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Patrick Kaltenbach sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, April 24th. The shares were sold at an average price of $54.50, for a total value of $109,000.00. Following the completion of the transaction, the insider now owns 42,132 shares in the company, valued at approximately $2,296,194. The disclosure for this sale can be found here. In the last quarter, insiders sold 147,119 shares of company stock worth $8,626,419.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2285314/neville-rodie-shaw-inc-has-482000-stake-in-agilent-technologies-inc-a.html
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.